Mangalam Drugs And Organics

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue49.5758.6067.3857.2379.56
Expenses62.0468.4380.6563.9888.55
EBITDA-2.81-1.32-5.531.02-0.98
EBIT-7.44-5.79-10.19-3.07-5.10
Profit Before Tax-12.47-9.84-13.27-6.75-8.99
Net Profit-7.35-9.84-13.42-7.64-7.21
Financial Ratios
Operating Profit Margin-5.70%-2.26%-8.22%1.77%-1.23%
Net Profit Margin-14.92%-16.86%-19.94%-13.38%-9.08%
Earning Per Share (Diluted)-4.64-6.21-8.48-4.83-4.55
Dividends Per Share0.000.000.000.000.00